135 related articles for article (PubMed ID: 332054)
1. [Therapeutical effects of bromocriptine (CB 154) in 10 acromegalic subjects. Study of somatotrophic function and clinical survey (author's transl)].
Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Blacker C
Ann Endocrinol (Paris); 1977; 38(4):291-301. PubMed ID: 332054
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutical effects of bromocriptine in 10 acromegalic patients: study of somatotrophic function and glucose tolerance test (author's transl)(proceedings)].
Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA
Ann Endocrinol (Paris); 1976; 37(4):299-300. PubMed ID: 1037360
[No Abstract] [Full Text] [Related]
3. Sleep-related growth hormone release following 2-bromo-alpha-ergocriptine treatment in acromegalic patients.
Chihara K; Kato Y; Abe H; Furumoto M; Maeda K
J Clin Endocrinol Metab; 1977 Jan; 44(1):78-84. PubMed ID: 576232
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of acromegaly using bromocriptine].
Köbberling J; Schwinn G; Dirks H
Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
Oppizzi G; Liuzzi A; Chiodini P; Dallabonzana D; Spelta B; Silvestrini F; Borghi G; Tonon C
J Clin Endocrinol Metab; 1984 Jun; 58(6):988-92. PubMed ID: 6725515
[TBL] [Abstract][Full Text] [Related]
6. [Bromocriptine therapy in acromegaly (author's transl)(proceedings)].
Schaison G; Mowszowicz I
Ann Endocrinol (Paris); 1976; 37(4):297-8. PubMed ID: 1037359
[No Abstract] [Full Text] [Related]
7. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
[TBL] [Abstract][Full Text] [Related]
8. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
Lamberts SW; Zweens M; Verschoor L; del Pozo E
J Clin Endocrinol Metab; 1986 Jul; 63(1):16-9. PubMed ID: 2872225
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine treatment of acromegaly.
Cassar J; Mashiter K; Joplin GF
Metabolism; 1977 May; 26(5):539-46. PubMed ID: 576725
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine therapy in acromegaly. A long-term review of 35 cases.
Sachdev Y; Gopal K; Garg VK
Postgrad Med J; 1981 Apr; 57(666):210-6. PubMed ID: 7027229
[TBL] [Abstract][Full Text] [Related]
11. Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegaly.
Dallabonzana D; Liuzzi A; Oppizzi G; Verde G; Chiodini PG; Dorow R; Horowski R
J Endocrinol Invest; 1985 Apr; 8(2):147-51. PubMed ID: 4031381
[TBL] [Abstract][Full Text] [Related]
12. [Results of CB 154 in the treatment of acromegaly in France (author's transl)(proceedings)].
Bricaire H
Ann Endocrinol (Paris); 1976; 37(4):305-8. PubMed ID: 1037363
[No Abstract] [Full Text] [Related]
13. Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months.
Schwinn G; Dirks H; McIntosh C; Köbberling J
Eur J Clin Invest; 1977 Apr; 7(2):101-7. PubMed ID: 404154
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine acute effect on insulin, glucagon and growth hormone levels in acromegalic patients.
Fedele D; Molinari M; Meneghel A; Valerio A; Muggeo M; Tiengo A
J Endocrinol Invest; 1980; 3(2):149-53. PubMed ID: 6993548
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Liuzzi A; Chiodini PG
J Clin Endocrinol Metab; 1986 Mar; 62(3):601-4. PubMed ID: 3080469
[TBL] [Abstract][Full Text] [Related]
16. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1984 Jun; 106(2):175-83. PubMed ID: 6145276
[TBL] [Abstract][Full Text] [Related]
17. No effect of treatment with sodium valproate on plasma growth hormone in bromocriptine unresponsive acromegaly.
Nortier JW; Croughs RJ; Schwarz F; Thijssen JH
Acta Endocrinol (Copenh); 1986 Feb; 111(2):162-4. PubMed ID: 3082095
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
Chiodini PG; Liuzzi A; Muller EE; Botalla L; Cremascoli G; Oppizzi G; Verde G; Silvestrini F
J Clin Endocrinol Metab; 1976 Aug; 43(2):356-63. PubMed ID: 950367
[TBL] [Abstract][Full Text] [Related]
19. Effect of different dopaminergic agents in the treatment of acromegaly.
Colao A; Ferone D; Marzullo P; Di Sarno A; Cerbone G; Sarnacchiaro F; Cirillo S; Merola B; Lombardi G
J Clin Endocrinol Metab; 1997 Feb; 82(2):518-23. PubMed ID: 9024247
[TBL] [Abstract][Full Text] [Related]
20. Effect of CB-154 therapy on the glucose tolerance, IRI and GH response to glucose administration in acromegaly.
Demura R; Yamaguchi H; Demura H; Shizume K
Endocrinol Jpn; 1978 Aug; 25(4):355-9. PubMed ID: 710371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
